From Proteopedia
			(Difference between revisions)
												
			proteopedia linkproteopedia link
			
			
			
			
			
			
				|  |  | 
		| Line 1: | Line 1: | 
| - | [[Image:1avt.gif|left|200px]] | + | {{Seed}} | 
|  | + | [[Image:1avt.png|left|200px]] | 
|  |  |  |  | 
|  | <!-- |  | <!-- | 
| Line 9: | Line 10: | 
|  | {{STRUCTURE_1avt|  PDB=1avt  |  SCENE=  }}  |  | {{STRUCTURE_1avt|  PDB=1avt  |  SCENE=  }}  | 
|  |  |  |  | 
| - | '''SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX'''
 | + | ===SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX=== | 
|  |  |  |  | 
|  |  |  |  | 
| - | ==Overview==
 | + | <!--  | 
| - | In order to probe the structural basis of stereoselectivity in the serine protease family, a series of enantiomeric boronic acids RCH2CH(NHCOCH3)B(OH)2 has been synthesized and kinetically characterized as transition-state analog inhibitors using alpha-chymotrypsin and subtilisin Carlsberg as model systems. When the R-substituent in thisseries was changed from a p-chlorophenyl to a 1-naphthyl group,alpha-chymotrypsin,but not subtilisin, reversed its usual preference for l-enantiomers and bound more tightly to theD-enantiomer [Martichonok, V., & Jones, J.B. (1996)J. Am. Chem. Soc. 118,950-958]. The structural factors responsible for thedifferences in stereoselectivity between the two enzymes have been explored by X-ray crystallographic examination of subtilisin Carlsberg and gamma-chymotrypsin complexes of the L- and D-enantiomers of p-chlorophenyl and 1-naphthyl boronic acid derivatives.In both enzymes, the L-isomers of the inhibitors, which are more closely related to the natural L-amino acid substrates, form tetrahedral adducts, covalently linking the central boron atom and Ogamma of the catalytic serine. The d-isomers, however, differ in the way they interact with subtilisin or gamma-chymotrypsin. With subtilisin, both the D-p-chlorophenyl and D-1-naphthyl inhibitor complexes form covalent Ser Ogamma-to-boron bonds, but with gamma-chymotrypsin, the same inhibitors lead to novel tetrahedral adducts covalently linking both Ser195 Ogamma and His57 Nepsilon2 covalently via the boron atom.
 | + | The line below this paragraph, {{ABSTRACT_PUBMED_9425066}}, adds the Publication Abstract to the page  | 
|  | + | (as it appears on PubMed at http://www.pubmed.gov), where 9425066 is the PubMed ID number. | 
|  | + | --> | 
|  | + | {{ABSTRACT_PUBMED_9425066}} | 
|  |  |  |  | 
|  | ==About this Structure== |  | ==About this Structure== | 
| Line 32: | Line 36: | 
|  | [[Category: Hydrolase]] |  | [[Category: Hydrolase]] | 
|  | [[Category: Serine protease]] |  | [[Category: Serine protease]] | 
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 10:45:14 2008'' | + |   | 
|  | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 17:42:30 2008'' | 
Revision as of 14:42, 30 June 2008
Template:STRUCTURE 1avt 
 SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
Template:ABSTRACT PUBMED 9425066
 About this Structure
1AVT is a Single protein structure of sequence from Bacillus licheniformis. Full crystallographic information is available from OCA. 
 Reference
Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes., Stoll VS, Eger BT, Hynes RC, Martichonok V, Jones JB, Pai EF, Biochemistry. 1998 Jan 13;37(2):451-62. PMID:9425066
Page seeded by OCA  on Mon Jun 30 17:42:30 2008